(Q37718718)

English

TRAIL/TRAIL-R in hematologic malignancies

scientific article published on May 2010

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

22 August 2017

1 reference

Europe PubMed Central

title

TRAIL/TRAIL-R in hematologic malignancies (English)

1 reference

stated in

Europe PubMed Central

22 August 2017

Ugo Testa

1

1 reference

stated in

Europe PubMed Central

22 August 2017

1 May 2010

1 reference

stated in

Europe PubMed Central

22 August 2017

Journal of Cellular Biochemistry

1 reference

stated in

Europe PubMed Central

22 August 2017

110

1 reference

stated in

Europe PubMed Central

22 August 2017

1

1 reference

stated in

Europe PubMed Central

22 August 2017

21-34

1 reference

stated in

Europe PubMed Central

22 August 2017

Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.22549

retrieved

21 January 2018

Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.22549

retrieved

21 January 2018

Bone marrow stroma confers resistance to Apo2 ligand/TRAIL in multiple myeloma in part by regulating c-FLIP.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.22549

retrieved

21 January 2018

CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.22549

retrieved

21 January 2018

Selective Inhibition of I B Kinase Sensitizes Mantle Cell Lymphoma B Cells to TRAIL by Decreasing Cellular FLIP Level

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.22549

retrieved

21 January 2018

Resistance to Apo2 ligand (Apo2L)/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis and constitutive expression of Apo2L/TRAIL in human T-cell leukemia virus type 1-infected T-cell lines.

1 reference

stated in

COCI

reference URL

https://opencitations.net/index/api/v1/citations/10.1128/JVI.79.3.1367-1378.2005

retrieved

30 December 2023

Identifiers

DOI

10.1002/JCB.22549

1 reference

stated in

Europe PubMed Central

22 August 2017

1 reference

Europe PubMed Central

PubMed ID

20336667

retrieved

22 August 2017

(Q37718718)

TRAIL/TRAIL-R in hematologic malignancies

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)